6. Tarney C. M., Han J. Postcoital bleeding: a review on etiology, diagnosis, and management. Obstet Gynecol Int 2014; 2014: 192087.
9
7. Royal College of Obstetricians & Gynaecologists. Ovarian Masses in Premenopausal Women, Management of Suspected (Green-top Guideline No. 62). 2011.
10
8. Parkin DM, Boyd L, Walker LC. 16. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011; 105 Suppl 2: S77–81.
11
1. Johnson S, Marriott L, Zinaman M. Can apps and calendar methods predict ovulation with accuracy? Curr Med Res Opin 2018: 1–18.
12
2. Dasharathy SS, Mumford SL, Pollack AZ, et al. Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol 2012; 175(6): 536–45.
13
3. Cole LA, Ladner DG, Byrn FW. The normal variabilities of the menstrual cycle. Fertil Steril 2009; 91(2): 522–7.
14
4. Howard C, Rose CL, Trouton K, et al. FLOW (finding lasting options for women): multicentre randomized controlled trial comparing tampons with menstrual cups. Can Fam Physician 2011; 57(6): e208–15.
15
5. Meaddough EL, Olive DL, Gallup P, Perlin M, Kliman HJ. Sexual activity, orgasm and tampon use are associated with a decreased risk for endometriosis. Gynecol Obstet Invest 2002; 53(3): 163–9.
16
Автор – британка, и адресована ее книга прежде всего британкам, поэтому многие реалии и отсылки в тексте относятся исключительно к Великобритании и населению этой страны (например, особенности системы здравоохранения или законодательство об абортах). В России и других странах ситуация, конечно, другая, и это следует учитывать. – Прим. перев.
17
6. Mitchell MA, Bisch S, Arntfield S, Hosseini-Moghaddam SM. A confirmed case of toxic shock syndrome associated with the use of a menstrual cup. Can J Infect Dis Med Microbiol 2015; 26(4): 218–20.
18
7. Archer JC, Mabry-Smith R, Shojaee S, Threet J., Eckert JJ, Litman VE. Dioxin and furan levels found in tampons. J Womens Health (Larchmt) 2005; 14(4): 311–5.
19
8. DeVito MJ, Schecter A. Exposure assessment to dioxins from the use of tampons and diapers. Environ Health Perspect 2002; 110(1): 23–8.
20
9. Strotmeyer ES, Steenkiste AR, Foley TP, Jr., Berga SL, Dorman JS. Menstrual cycle differences between women with type 1 diabetes and women without diabetes. Diabetes Care 2003; 26(4): 1016–21.
21
10. Solomon CG, Hu FB, Dunaif A, et al. Long or highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001; 286(19): 2421–6.
22
11. Teede H, Deeks A, Moran L. Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan. BMC Med 2010; 8: 41.
23
12. Mavropoulos JC, Yancy WS, Hepburn J, Westman EC. The effects of a low-carbohydrate, ketogenic diet on the polycystic ovary syndrome: a pilot study. Nutr Metab (Lond) 2005; 2: 35.
24
13. Lee I, Cooney LG, Saini S, et al. Increased risk of disordered eating in polycystic ovary syndrome. Fertil Steril 2017; 107(3): 796–802.
25
14. Eslamian G, Baghestani AR, Eghtesad S, Hekmatdoost A. Dietary carbohydrate composition is associated with polycystic ovary syndrome: a case-control study. J Hum Nutr Diet 2017; 30(1): 90–7.
26
15. Cooney LG, Lee I, Sammel MD, Dokras A. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and metaanalysis. Hum Reprod 2017; 32(5): 1075–91.
27
16. Naderpoor N, Shorakae S, de Courten B, Misso ML, Moran LJ, Teede HJ. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update 2016; 22(3).
28
17. Pundir J, Psaroudakis D, Savnur P, et al. Inositol treatment of anovulation in women with polycystic ovary syndrome: a metaanalysis of randomised trials. BJOG 2018; 125(3): 299–308.
29
18. Metcalf MG, Skidmore DS, Lowry GF, Mackenzie JA. Incidence of ovulation in the years after the menarche. J Endocrinol 1983; 97(2): 213–9.
30
19. Harris HR, Titus LJ, Cramer DW, Terry KL. Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study. Int J Cancer 2017; 140(2): 285–91.
31
20. Harris HR, Terry KL. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review. Fertil Res Pract 2016; 2: 14.
32
21. Friberg E, Mantzoros CS, Wolk A. Diabetes and risk of endometrial cancer: a population-based prospective cohort study. Cancer Epidemiol Biomarkers Prev 2007; 16(2): 276–80.
33
